Laird Norton Wetherby Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,440	Closed	-$993K	–	906
2022 Q2	$993K	Buy	8,440 +3,700	+78%	+$439K	0.07%	297
2022 Q1	$618K	Buy	4,740 +780	+20%	+$102K	0.04%	443
2021 Q4	$605K	Buy	3,960 +1,000	+34%	+$155K	0.03%	457
2021 Q3	$478K	Hold	2,960	–	–	0.03%	525
2021 Q2	$484K	Buy	+2,960	New	+$456K	0.03%	525
2021 Q1	–	Sell	-2,960	Closed	-$448K	–	834
2020 Q4	$448K	Buy	+2,960	New	+$423K	0.03%	496
2018 Q1	–	Sell	-600	Closed	-$64K	–	658
2017 Q4	$64K	Hold	600	–	–	0.01%	640
2017 Q3	$67K	Buy	+600	New	+$64.1K	0.01%	613

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's IBB Position: Q3 2022 in Review

Laird Norton Wetherby Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 8,440 shares — an estimated $993K sold.

Laird Norton Wetherby Wealth Management first reported a position in IBB in Q3 2017 and held it in 8 quarters. The position peaked at $993K in Q2 2022. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Laird Norton Wetherby Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Laird Norton Wetherby Wealth Management sold 8,440 iShares Biotechnology ETF shares in Q3 2022, an estimated $993K.
Laird Norton Wetherby Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 8 quarters.
Laird Norton Wetherby Wealth Management's iShares Biotechnology ETF position peaked at $993K in Q2 2022.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.